Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.00%
1,089.59
-10.98
-1.00%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.01%
605.06
-0.090
-0.01%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.66%
1,215.04
+19.85
+1.66%
—1,195.191,204.711,217.721,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.55%
1,713.01
-26.90
-1.55%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.56%
642.15
+3.59
+0.56%
—638.56640.21645.32639.66——
SIXR
Staples
SIXR
Staples
SIXR
+1.29%
842.27
+10.70
+1.29%
—831.57840.48843.98834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.73%
214.92
+1.56
+0.73%
—213.36213.36215.54212.77——
SIXT
Technology
SIXT
Technology
SIXT
-2.58%
3,151.60
-83.41
-2.58%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.32%
938.67
+3.02
+0.32%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.75%
1,460.16
+10.90
+0.75%
—1,449.261,454.771,462.651,452.87——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.64%
2,367.29
-15.16
-0.64%
—2,382.452,371.192,380.452,364.46——
DFTX:NASDAQ
Definium Therapeutics Inc
$21.17
+0.91%
(+0.19) 1D
Apr 28, 11:00:30 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DFTX...
Open
$20.83
High
$21.64
Low
$20.60
Mkt. cap
2.12B
Avg. vol.
1.92M
Volume
416.32K
52-wk high
$26.25
52-wk low
$14.62
EPS
-$2.06
Beta
2.55
Shares outstanding
99.70M
No. of employees
106
News stories
From sources across the web
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com
Last report
Nov 6, 2025
Fiscal Period
Q3 2025
Normalized EPS / Estimate
-0.78/ (-0.50 est.)USD
-54.84%miss
Revenue / Estimate
-/ (0.00 est.)USD
Fiscal Q3 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.36M
29.81M
30.98M
33.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.80M
11.09M
14.69M
14.06M
Operating expense
32.16M
40.90M
45.67M
47.58M
Total operating expenses
32.16M
40.90M
45.67M
47.58M
Operating income
-32.16M
-40.90M
-45.67M
-47.58M
Other non operating income
7.00M
-2.23M
-22.54M
-5.06M
EBT including unusual items
-23.35M
-42.74M
-67.26M
-50.44M
EBT excluding unusual items
-23.35M
-42.74M
-67.26M
-50.44M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23.35M
-42.74M
-67.26M
-50.44M
Net profit margin
-
-
-
-
Earnings per share
-0.35
-0.50
-0.78
-
Interest and investment income
2.43M
2.77M
2.26M
3.49M
Interest expense
-602.00K
-2.34M
-1.27M
-1.27M
Net interest expenses
1.83M
436.00K
988.00K
2.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-32.15M
-40.90M
-45.66M
-47.57M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer